SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021

Avula Laxmaiah; Nalam Madhusudhan Rao; N Arlappa; Jagjeevan Babu; P Uday Kumar; Priya Singh; Deepak Sharma; V Mahesh Anumalla; T Santhosh Kumar; R Sabarinathan; M Santhos Kumar; R Ananthan; D Anwar Basha; P P S Blessy; D Chandra Kumar; P Devaraj; S Devendra; M Mahesh Kumar; Indrapal I Meshram; B Naveen Kumar; Paras Sharma; P Raghavendra; P Raghu; K Rajender Rao; P Ravindranadh; B Santosh Kumar; G Sarika; J Srinivasa Rao; M V Surekha; F Sylvia; Deepak Kumar; G Subba Rao; Karthik Bharadwaj Tallapaka; Divya Tej Sowpati; Surabhi Srivastava; V Manoj Murhekar; Rajkumar Hemalatha; Rakesh K Mishra

doi:10.1016/j.ijregi.2021.10.009

SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021

IJID Reg. 2022 Mar:2:1-7. doi: 10.1016/j.ijregi.2021.10.009. Epub 2021 Nov 19.

Authors

Avula Laxmaiah¹, Nalam Madhusudhan Rao², N Arlappa¹, Jagjeevan Babu¹, P Uday Kumar¹, Priya Singh², Deepak Sharma², V Mahesh Anumalla², T Santhosh Kumar², R Sabarinathan³, M Santhos Kumar³, R Ananthan¹, D Anwar Basha¹, P P S Blessy¹, D Chandra Kumar¹, P Devaraj¹, S Devendra¹, M Mahesh Kumar¹, Indrapal I Meshram¹, B Naveen Kumar¹, Paras Sharma¹, P Raghavendra¹, P Raghu¹, K Rajender Rao¹, P Ravindranadh¹, B Santosh Kumar¹, G Sarika¹, J Srinivasa Rao¹, M V Surekha¹, F Sylvia¹, Deepak Kumar¹, G Subba Rao¹, Karthik Bharadwaj Tallapaka², Divya Tej Sowpati², Surabhi Srivastava², V Manoj Murhekar³, Rajkumar Hemalatha¹, Rakesh K Mishra²

Affiliations

¹ ICMR-National Institute of Nutrition, Tarnaka, Hyderabad.
² CSIR-Centre for Cellular and Molecular Biology, Habsiguda, Hyderabad.
³ ICMR-National Institute of Epidemiology, Chennai.

Abstract

Background: COVID-19 emerged as a global pandemic in 2020, spreading rapidly to most parts of the world. The proportion of infected individuals in a population can be reliably estimated via serosurveillance, making it a valuable tool for planning control measures. Our serosurvey study aimed to investigate SARS-CoV-2 seroprevalence in the urban population of Hyderabad at the end of the first wave of infections.

Methods: This cross-sectional survey, conducted in January 2021 and including males and females aged 10 years and above, used multi-stage random sampling. 9363 samples were collected from 30 wards distributed over six zones of Hyderabad, and tested for antibodies against SARS-CoV-2 nucleocapsid antigen.

Results: Overall seropositivity was 54.2%, ranging from 50% to 60% in most wards. Highest exposure appeared to be among those aged 30-39 and 50-59 years, with women showing greater seropositivity. Seropositivity increased with family size, with only marginal differences among people with varying levels of education. Seroprevalence was significantly lower among smokers. Only 11% of the survey subjects reported any COVID-19 symptoms, while 17% had appeared for COVID-19 testing.

Conclusion: Over half the city's population was infected within a year of onset of the pandemic. However, ∼ 46% of people remained susceptible, contributing to subsequent waves of infection.

Keywords: ACE2, angiotensin-converting enzyme 2; CCMB, Centre for Cellular and Molecular Biology; CI, confidence interval; COI, cutoff index; COVID-19; COVID-19, coronavirus disease; CSIR, Council of Scientific and Industrial Research; GHMC, Greater Hyderabad Municipal Corporation; Hyderabad; ICMR, Indian Council of Medical Research; India; NIN, National Institute of Nutrition; ODK, Open Data Kit; RT-PCR, reverse-transcription polymerase chain reaction; SARS, severe acute respiratory syndrome; SARS-CoV-2 antibody; SD, standard deviation; SPSS, Statistical Package for the Social Sciences; seroprevalence; serosurveillance.